Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb

Oncogene

Volumn 25, Issue 5, 2006, Pages 795-805

  Liu, F ^a   Lei, W ^a,c   O'Rourke, J P ^a   Ness, S A ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Differentiation; Hematopoiesis; Leukemia; Myb oncogene; Transformation

Indexed keywords

PROTEIN MYB;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AVIAN MYELOBLASTOSIS VIRUS; CARBOXY TERMINAL SEQUENCE; CELL TYPE; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; GENE MUTATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA; NONHUMAN; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MYB; TRANSCRIPTION, GENETIC;

ANIMALIA; AVIAN MYELOBLASTOSIS VIRUS; GALLUS GALLUS;

EID: 32244445606     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209105     Document Type: Article

References (43)

1. Butz NV, Campbell CE, Gronostajski RM. (2004). Gene 342: 67-76.
2. Chayka O, Kintscher J, Braas D, Klempnauer KH. (2005). Mol Cell Biol 25: 499-511.
3. Chen X, Bieker JJ. (2004). Mol Cell Biol 24: 10416-10424.
4. Dash AB, Orrico FC, Ness SA. (1996). Genes Dev 10: 1858-1869.
5. Dini PW, Eltman JT, Lipsick JS. (1995). J Virol 69: 2515-2524.
6. Dini PW, Lipsick JS. (1993). Mol Cell Biol 13: 7334-7348.
7. Epstein JA, Song B, Lakkis M, Wang C. (1998). Mol Cell Biol 18: 4118-4130.
8. Frykberg L, Metz T, Brady G, Introna M, Beug H, Vennström B et al. (1988). Oncogene Res 3: 313-322.
9. Fu S-L, Lipsick JS. (1996). J Virol 70: 5600-5610.
10. Gonda TJ, Ramsay RG, Johnson GR. (1989). EMBO J 8: 1767-1775.
11. Grässer FA, LaMontagne K, Whittaker L, Stohr S, Lipsick J. (1992). Oncogene 7: 1005-1009.
12. Hodges LC, Cook JD, Lobenhofer EK, Li L, Bennett L, Bushel PR et al. (2003). Mol Cancer Res 1: 300-311.
13. Hou DX, Akimaru H, Ishii S. (1997). FEBS Lett 413: 60-64.
14. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T et al. (1994). J Biol Chem 269: 32451-32456.
15. Introna M, Golay J, Frampton J, Nakano T, Ness SA, Graf T. (1990). Cell 63: 1289-1297.
16. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. (2004). Mol Cell 14: 175-182.
17. Kowenz-Leutz E, Herr P, Niss K, Leutz A. (1997). Cell 91: 185-195.
18. Lang G, White JR, Argent-Katwala MJ, Allinson CG, Weston K. (2005). Oncogene 24: 1375-1384.
19. Lei W, Liu F, Ness SA. (2005). Blood 105: 3855-3861.
20. Lei W, Rushton JJ, Davis LM, Liu F, Ness SA. (2004). J Biol Chem 279: 29519-29527.
21. Leverson JD, Koskinen PJ, Orrico FC, Rainio E-M, Jalkanen KJ, Dash AB et al. (1998). Mol Cell 2: 417-425.
22. Leverson JD, Ness SA. (1998). Mol Cell 1: 203-211.
23. Lipsick JS. (1996). Oncogene 13: 223-235.
24. Lipsick JS, Wang DM. (1999). Oncogene 18: 3047-3055.
25. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. (1991). Cell 65: 677-689.
26. Muller C, Yang R, Idos G, Tidow N, Diederichs S, Koch OM et al. (1999). Blood 94: 4255-4262.
27. Ness SA. (1996). Biochim Biophys Acta 1288: F123-F139.
28. Ness SA. (2003). Blood Cells Mol Dis 31: 192-200.
29. Ness SA, Engel JD. (1994). Curr Opin Genet Dev 4: 718-724.
30. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A. (1993). Genes Dev 7: 749-759.
31. Ness SA, Marknell Å, Graf T. (1989). Cell 59: 1115-1125.
32. Oh IH, Reddy EP. (1999). Oncogene 18: 3017-3033.
33. Plaza S, Turque N, Dozier C, Bailly M, Saule S. (1995). Oncogene 10: 329-340.
34. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A, Ness SA. (2003). Oncogene 22: 308-313.
35. Rushton JJ, Ness SA. (2001). Blood Cells Mol Dis 27: 459-463.
36. Sun-Hoffman L, Aurigemma RE, Sun B, Ruscetti SK. (1996). Oncogene 13: 1037-1042.
37. Szczylik C, Skorski T, Ku DH, Nicolaides NC, Wen SC, Rudnicka L et al. (1993). J Exp Med 178: 997-1005.
38. Takahashi H, Mitani Y, Satoh N. (2005). Dev Growth Differ 47: 173-185.
39. Tanno B, Negroni A, Vitali R, Pirozzoli MC, Cesi V, Mancini C et al. (2002). J Biol Chem 24: 24.
40. Todokoro K, Watson RJ, Higo H, Amanuma H, Kuramochi S, Yanagisawa H et al. (1988). Proc Natl Acad Sci USA 85: 8900-8904.
41. Travali S, Ferber A, Reiss K, Sell C, Koniecki J, Calabretta B et al. (1991). Oncogene 6: 887-894.
42. Weston KM. (1990). Seminars in Cancer Biology 1: 371-382.
43. Winn LM, Lei W, Ness SA. (2003). Cell Cycle 2: 258-262.